M Ventures
Scipio bioscience announces €6m Series A funding led by M Ventures
– FRANCE, Paris – Scipio bioscience, a Paris-based biotechnology company, developing a new generation of single-cell sequencing solutions, announces today that it has secured a €6M Series A financing from an international syndicate led by M Ventures, the corporate venture capital arm of Merck.…
Ribometrix announces Hakan Goker to its Board along with raising $30m Series A financing led by M Ventures
– USA, NC – Ribometrix, a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases, announced today that it has completed a $30 million Series A financing to advance its discovery platform and internal pipeline of novel small molecule drugs that directly modulate RNA activity, as well as expand its team and business development activity.…
ApoGen Biotechnologies adds Dr Keno Gutierrez to its Board along with raising additional $4m Series A financing from M Ventures
– USA, WA – ApoGen Biotechnologies, Inc., a company developing a new class of drugs that target the underlying mechanisms that lead to the development of drug resistance by cancer cells, today announced the expansion of its Series A financing to a total of $11 million.…
Mosa Meat raised €7.5m funding co-led by M Ventures and Bell Food to bring cultured meat to market by 2021
– NETHERLANDS, Maastricht – Mosa Meat, a spin off company from Maastricht University, today announced that it has raised €7.5M to bring cultured meat to market by 2021.…